A5047594885- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Urologic and reproductive health conditions
- Genital Health and Disease
- Renal and Vascular Pathologies
- Anesthesia and Pain Management
- Smoking Behavior and Cessation
- Abdominal vascular conditions and treatments
- Testicular diseases and treatments
- Renal cell carcinoma treatment
- Sexual Differentiation and Disorders
- Healthcare Systems and Challenges
- Economic and Financial Impacts of Cancer
- Bladder and Urothelial Cancer Treatments
- Urological Disorders and Treatments
- COVID-19 and healthcare impacts
- Urinary Bladder and Prostate Research
- Esophageal Cancer Research and Treatment
- Health Systems, Economic Evaluations, Quality of Life
- Opioid Use Disorder Treatment
- Healthcare cost, quality, practices
City of Hope
2023-2024
Franciscan Health
2023
Virginia Mason Medical Center
2020-2021
Seattle University
2019-2020
Blue Cross Blue Shield of Michigan Foundation
2019
Jefferson University Hospitals
2017
Thomas Jefferson University Hospital
2017
Thomas Jefferson University
2016
Approximately two-thirds of men who undergo primary treatment for prostate cancer (PC) will experience biochemical recurrence (BCR). Salvage robot-assisted radical prostatectomy (sRARP) offers curative in this disease setting and choose option may avoid palliative androgen deprivation therapy (ADT). The purpose study was to describe long-term outcomes patient feedback following sRARP.
You have accessJournal of UrologyGeneral & Epidemiological Trends Socioeconomics: Quality Improvement Patient Safety I (MP10)1 Apr 2019MP10-08 LONG TERM CONSEQUENCE OF PERIOPERATIVE NARCOTIC EXPOSURE FOLLOWING ROBOTIC PROSTATECTOMY: AN EIGHT YEAR FOLLOW-UP STUDY Ryan Donahue*, Basil Ferenczi, Kathryn Dahl, Daniel Warren, Neil Hanson, Christopher Porter, Paul Kozlowski, and John Corman Donahue*Ryan Donahue* More articles by this author , FerencziBasil Ferenczi DahlKathryn Dahl WarrenDaniel...
INTRODUCTION AND OBJECTIVE: The National Comprehensive Cancer Network (NCCN) guidelines recommend active surveillance (AS) as the preferred management of low risk (LR) prostate cancer (PCa) and an option for those with favorable intermediate (FIR) PCa. We hypothesized trends would show AS increasing men LR FIR This study describes in PCa using Database (NCDB), which includes ∼50% new diagnoses United States per year. METHODS: NCDB was queried all patients localized (2010-2015). were defined...
You have accessJournal of UrologyPenile & Testicular Cancer: Penile Cancer III (MP76)1 Apr 2020MP76-14 PATIENTS OLDER THAN 38 WITH STAGE 3 NONSEMINOMA HAVE DECREASED SURVIVAL COMPARED TO YOUNGER Jason Frankel*, Nathan Jung, Basil Ferenczi, Christopher Porter, and John Paul Flores Frankel*Jason Frankel* More articles by this author , JungNathan Jung FerencziBasil Ferenczi PorterChristopher Porter FloresJohn View All Author Informationhttps://doi.org/10.1097/JU.0000000000000962.014AboutPDF...
e17514 Background: National Comprehensive Cancer Network (NCCN) guidelines recommend definitive treatment for high risk prostate cancer (HRPCa). This study aims to assess trends men with HRPCa, focusing on deemed the basis of an elevated PSA alone otherwise low features. Our hypothesis is that this group treated differently than other patients disease. Methods: The Database (NCDB) (PCa) participant use file was queried ages 18-75 biopsy proven PCa from 2010-2016. NCDB represents...
In order to assess whether bladder cancer is appropriately referenced in online anti-tobacco advertisements, we evaluated 200 videos and assessed diseases mentioned these videos. This was then compared relative incidence of tobacco-associated malignancy.Smoking cessation campaign were identified using the Google Video search page. The first 50 video results 4 colloquial terms for mentioned. Videos categorized as malignancy-related advertisement or all advertisement. Relative weight each...